Our Team

Dylan is a managing director at Insight Partners, where he leads the firm’s bio practice with a focus on investments at the intersection of computation and biology. He also serves on the boards of several private life sciences companies, including Superluminal Medicines, Unlearn, and Profluent. Previously, he was a general partner at CRV, where he helped build the firm’s bioengineering practice and led investments in Recursion Pharmaceuticals and Dyno Therapeutics. Prior to investing, he cofounded the diagnostics start-up, Integrated Plasmonics.

He received his AB in computer science from Harvard and conducted graduate research in biochemistry and molecular biophysics at Caltech.